Istituto Oncologico Veneto Irccs

This study tests whether giving the immunotherapy drug pembrolizumab along with standard chemotherapy before surgery can improve outcomes for people with a rare cancer called pleural mesothelioma. The trial involves 41 adults with early-stage disease that can be surgically remove…

This study looks at how well a combination of three drugs (capecitabine, oxaliplatin, and bevacizumab) works as a first treatment for elderly patients (70 years or older) with metastatic colorectal cancer that cannot be removed by surgery. The goal is to see how long the cancer s…

This study checks if a new, highly sensitive blood test (Plasma-SeqSensei) can find more EGFR gene mutations in people with advanced lung cancer than the current standard test. About 130 patients who already had a standard test will give a blood sample for the new test. The goal …

This study tests whether using a virtual reality headset during PICC or PICC-PORT placement can reduce anxiety and pain in cancer patients. About 120 adults will be randomly assigned to either receive VR plus standard care or standard care alone. The goal is to see if VR can impr…

This study looks at whether a short, 8-question screening tool called the G8 can help predict survival and severe side effects from treatment in people aged 70 and older with metastatic colorectal cancer. Researchers will also test a physical performance measure called Timed Up a…

This study looks at how brain tumors (gliomas) weaken the body's immune system. Researchers will use special MRI scans and tissue samples from 31 adult patients to find markers of immune suppression. The goal is to better understand the disease, not to test a new treatment.

This study looks at the financial burden (called financial toxicity) that people face after having robotic surgery for prostate, bladder, or kidney cancer. Researchers will ask 120 patients to fill out questionnaires about their expenses, travel costs, and support needs. The goal…